Compare Baxter International Inc (BAX) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Symbotic Inc — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while Symbotic Inc trades at $43.75 (market cap $5.55B). The key difference: Baxter International Inc is far larger — about 2× Symbotic Inc's market cap, and Baxter International Inc pays a 0.92% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| BAX | SYM | |
|---|---|---|
Market Cap | $11.26B | $5.55B |
Sector | Health | Technology |
52-Week High | $29.22 | $87.30 |
52-Week Low | $15.80 | $38.57 |
Enterprise Value | $18.93B | $3.54B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
Symbotic Inc. (SYM) trades at $42.43, down 2.77% on the day, with technical indicators signaling a bearish trend. The company reported revenue of $2.25 billion in 2025 but posted a net loss of $16.94 million, though gross margins improved to 20.43%. Recent news highlights the acquisition of ARMS Innovations, expanding its AI-powered warehouse optimization solutions. Analyst consensus remains positive with a $57.50 price target, but mixed earnings performance and high valuation ratios present challenges.
Outlook: SYM shows potential in the growing robotics and automation sector, supported by strong operating cash flow and strategic acquisitions. However, profitability concerns, high EV/EBITDA of 240.06, and competitive pressures pose significant risks. Investors should weigh the bullish analyst sentiment against fundamental weaknesses and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
